Zentek LtdTSXV:ZENView on NASDAQ
- LAST PRICE1.5000
- TODAY'S CHANGE (%)-0.0200 (-1.3158%)
- Bid / Lots1.5000/ 39
- Ask / Lots1.5300/ 10
- Open / Previous Close1.5200 / 1.5200
- Day Range
- 52 Week Range
- Volume35,230
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZEN |
|---|---|---|
| 09:32 ET | 1000 | 1.52 |
| 09:59 ET | 200 | 1.52 |
| 10:37 ET | 8800 | 1.51 |
| 11:44 ET | 3100 | 1.51 |
| 12:02 ET | 100 | 1.52 |
| 12:52 ET | 3400 | 1.5 |
| 01:26 ET | 6000 | 1.49 |
| 02:29 ET | 900 | 1.48 |
| 02:31 ET | 1500 | 1.47 |
| 02:36 ET | 6000 | 1.47 |
| 02:42 ET | 1800 | 1.47 |
| 02:44 ET | 100 | 1.49 |
| 03:03 ET | 500 | 1.49 |
| 03:27 ET | 300 | 1.51 |
| 03:30 ET | 300 | 1.5 |
| 03:59 ET | 1100 | 1.5 |
Apr 3, 2024
Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions, from 8:26AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:26AM ET on Wednesday Apr 03, 2024 by Dow Jones
Mar 25, 2024
Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Biosciences Ltd. for C19HBA, from 8:01AM ET on Monday Mar 25, 2024 by Dow Jones
8:01AM ET on Monday Mar 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentek Ltd | 152.6M | -12.5x | --- |
Alpha Cognition Inc | 107.5M | -3.6x | --- |
Cardiol Therapeutics Inc | 163.9M | -5.4x | --- |
Arch Biopartners Inc | 148.7M | -76.3x | --- |
Eupraxia Pharmaceuticals Inc | 127.7M | -2.3x | --- |
Medicenna Therapeutics Corp | 120.0M | -7.5x | --- |
Company Information
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
Contact Information
- Headquarters
- 24 Corporate CtGUELPH, ON, Canada N1G 5G5
- Phone
- 705-618-0900
- Fax
- 705-618-0900
Executives
- Non-Executive Chairman of the Board
- Eric Wallman
- Independent Director
- Gregory Fenton
- Chief Financial Officer
- Wendy Ford
- Chief Operating Officer, Director
- Francis Dube
- Head of Research
- Colin Van Der Kuur
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $152.6M |
|---|---|
Revenue (TTM) | $33.6K |
Shares Outstanding | 100.8M |
Zentek Ltd does not pay a dividend. | |
Beta | 0.86 |
EPS | $-0.12 |
Book Value | $0.31 |
P/E Ratio | -12.5x |
Price/Sales (TTM) | 4,540.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -38,421.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
